发明名称 Treatment of huntington'S disease
摘要 The present invention relates to a method of treatment and/or ameliorating the symptoms of Huntington's disease comprising the step of administering an effective amount of adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier to an individual in need thereof. Preferably, the administration is via intramuscular injection.
申请公布号 US9408865(B2) 申请公布日期 2016.08.09
申请号 US201414539305 申请日期 2014.11.12
申请人 Genix Therapeutics Group, LLC 发明人 El-Rashidy Ragab
分类号 A61K38/43;A61K31/714;A61K31/7076;A61K31/675;A61K31/455;A61K9/00;A61K9/19;A61K31/51 主分类号 A61K38/43
代理机构 Olson & Cepuritis, Ltd. 代理人 Olson & Cepuritis, Ltd.
主权项 1. A method for ameliorating loss of grip strength in a patient suffering from Huntington's Disease which comprises administering to the patient an effective amount of a composition comprising adenosine triphosphate, co-carboxylase, nicotinamide, and cyanocobalamin in a physiologically acceptable carrier, wherein the administration is by intramuscular injection, and wherein the effective amount administered comprises about 10-50 parts by weight adenosine triphosphate, about 50-250 parts by weight co-carboxylase, about 20-100 parts by weight nicotinamide, and about 0.5-1 parts by weight cyanocobalamin.
地址 Skokie IL US